Page 1 | Search Results | Blood | American Society of Hematology

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Angiogenic Molecules and Inflammatory Cytokines in Patients with Thalassemia Major and Double Heterozygous HbS/Beta-Thalassemia; the impact of Deferasirox.

Ersi Voskaridou, Dimitrios Christoulas, Athanasios Papatheodorou, Eleni Plata, Charoula Xirakia, Panayiotis Tsaftaridis, Georgios Boutsikas, Evangelos Terpos

Blood (2009) 114 (22): 2018.

https://doi.org/10.1182/blood.V114.22.2018.2018

Published: 2009

Journal Articles

Deferasirox Reduces Serum TNF-α but Impairs Renal Function in Patients with Thalassemia Major after 12 Months of Therapy

Ersi Voskaridou, Eleni Plata, Dimitrios Christoulas, Charoula Xirakia, Eleni Stoupa, Konstantinos Varvagiannis, Antonios Bilalis, Athanasios Papatheodorou, Panagiotis Tsaftaridis, Evangelos Terpos

Blood (2008) 112 (11): 3888.

https://doi.org/10.1182/blood.V112.11.3888.3888

Published: 2008

Journal Articles

Serum Dickkopf-1 Is Increased and Correlates with Bone Mineral Density in Patients with Thalassemia-Induced Osteoporosis. Reduction Post Zoledronic Acid Administration

Ersi Voskaridou, Dimitrios Christoulas, Thodoris Pantelaros, Konstantinos Varvagiannis, Charoula Xirakia, Athanasios Papatheodorou, Kleio Sinopoulou, Aggeliki Mpalasopoulou, Antonios Bilalis, Evangelos Terpos

Blood (2008) 112 (11): 3889.

https://doi.org/10.1182/blood.V112.11.3889.3889

Published: 2008

Journal Articles

Dysfunction of Toll-Like Receptor-2, −4, and −6: Is There a Role in the Pathogenesis of Immunodeficiency in Multiple Myeloma?.

Evangelos Terpos, Meletios A. Dimopoulos, Charoula Xirakia, Dimitrios Christoulas, Athanasios Anagnostopoulos, Eirini Katodritou, Kostas Zervas, Paschalis Sideras, Konstantinos Tsionos, Evangelos Andreakos

Blood (2006) 108 (11): 3430.

https://doi.org/10.1182/blood.V108.11.3430.3430

Published: 2006

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Angiogenic Molecules and Inflammatory Cytokines in Patients with Thalassemia Major and Double Heterozygous HbS/Beta-Thalassemia; the impact of Deferasirox.

Deferasirox Reduces Serum TNF-α but Impairs Renal Function in Patients with Thalassemia Major after 12 Months of Therapy

Serum Dickkopf-1 Is Increased and Correlates with Bone Mineral Density in Patients with Thalassemia-Induced Osteoporosis. Reduction Post Zoledronic Acid Administration

Dysfunction of Toll-Like Receptor-2, −4, and −6: Is There a Role in the Pathogenesis of Immunodeficiency in Multiple Myeloma?.

Email alerts

ASH Publications

American Society of Hematology

Update search

Angiogenic Molecules and Inflammatory Cytokines in Patients with Thalassemia Major and Double Heterozygous HbS/Beta-Thalassemia; the impact of Deferasirox.

Deferasirox Reduces Serum TNF-α but Impairs Renal Function in Patients with Thalassemia Major after 12 Months of Therapy

Serum Dickkopf-1 Is Increased and Correlates with Bone Mineral Density in Patients with Thalassemia-Induced Osteoporosis. Reduction Post Zoledronic Acid Administration

Dysfunction of Toll-Like Receptor-2, −4, and −6: Is There a Role in the Pathogenesis of Immunodeficiency in Multiple Myeloma?.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only